SoundararajanVPatelNSubramanianVSasisekharanVSasisekharanR. The many faces of the YopM effector from plague causative bacterium Yersinia pestis and its implications for host immune modulation. Innate Immun2011; 17–17. Epub ahead of print: 10 August 2010. DOI: 10.1177/1753425910377099.
2.
SoundararajanVPatelNSubramanianVSasisekharanVSasisekharanR. Atomic interaction networks in the core of protein domains and their native folds. PLoS One201023; 5: e9391–e9391.
3.
BolandAHavauxSCornelisGR. Heterogeneity of the Yersinia YopM protein. Microb Pathog1998; 25: 343–348.
4.
EvdokimovAGAndersonDERoutzahnKMWaughDS. Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unit. J Mol Biol2001; 312: 807–821.
5.
RohdeJRBreitkreutzAChenalASansonettiPJParsotC. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe2007; 1: 77–83.
6.
SingerAURohdeJRLamRSkarinaTKaganODileoR. Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases. Nat Struct Mol Biol2008; 15: 1293–1301.
7.
QuezadaCMHicksSWGalánJEStebbinsCE. A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases. Proc Natl Acad Sci U S A2009; 106: 4864–4869.
8.
Bernal-BayardJRamos-MoralesF. Salmonella type III secretion effector SlrP is an E3 ubiquitin ligase for mammalian thioredoxin. J Biol Chem2009; 284: 27587–27595.
9.
Bernal-BayardJCardenal-MuñozERamos-MoralesF. The Salmonella type III secretion effector, salmonella leucine-rich repeat protein (SlrP), targets the human chaperone ERdj3. J Biol Chem2010; 285: 16360–16368.
10.
AshidaHKimMSchmidt-SupprianMMaAOgawaMSasakawaC. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat Cell Biol2010; 12: 66–73.
11.
ZhuYLiHHuLWangJZhouYPangZLiuLShaoF. Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat Struct Mol Biol2008; 15: 1302–1308.
12.
MontminySWKhanNMcGrathSWalkowiczMJSharpFConlonJE. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol2006; 7: 1066–1073.
13.
PalmerLEHobbieSGalánJEBliskaJB. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol1998; 27: 953–965.
14.
OrthKPalmerLEBaoZQStewartSRudolphAEBliskaJBDixonJE. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science1999; 285: 1920–1923.
15.
TelepnevMVKlimpelGRHaithcoatJKnirelYAAnisimovAPMotinVL. Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells. J Infect Dis2009; 200: 1694–1702. Erratum in: J Infect Dis 2010; 201: 314.
16.
KerschenEJCohenDAKaplanAMStraleySC. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun2004; 72: 4589–4602.
17.
McCoyMWMarréMLLesserCFMecsasJ. The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence. Infect Immun2010; 78: 2584–2598.
18.
McPheeJBMenaPBliskaJB. Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence. Infect Immun2010; 78: 3529–3539.